dexamethason krka tablett
krka d.d. novo mesto - deksametasoon - tablett - 0,5mg 100tk; 0,5mg 90tk; 0,5mg 60tk; 0,5mg 10tk; 0,5mg 30tk; 0,5mg 20tk
parafizz kihisev tablett
cipla europe nv - paratsetamool - kihisev tablett - 1000mg 12tk; 1000mg 10tk; 1000mg 16tk; 1000mg 32tk; 1000mg 50tk; 1000mg 20tk; 1000mg 100tk; 1000mg 8tk
parafizz kihisev tablett
cipla europe nv - paratsetamool - kihisev tablett - 500mg 20tk; 500mg 12tk; 500mg 10tk; 500mg 16tk; 500mg 8tk; 500mg 24tk; 500mg 50tk; 500mg 32tk; 500mg 60tk
solpadeine express kihisev tablett
richard bittner ag - paratsetamool+kofeiin - kihisev tablett - 500mg+65mg 6tk; 500mg+65mg 60tk; 500mg+65mg 16tk; 500mg+65mg 48tk; 500mg+65mg 12tk; 500mg+65mg 24tk
zulfija kaetud tablett
gedeon richter plc. - gestodeen+etünüülöstradiool - kaetud tablett - 75mcg+30mcg 63tk; 75mcg+30mcg 126tk; 75mcg+30mcg 21tk
novynette plus õhukese polümeerikattega tablett
gedeon richter plc. - desogestreel+etünüülöstradiool - õhukese polümeerikattega tablett - 0+0/150mcg+20mcg 21tk / 63tk; 0+0/150mcg+20mcg 7tk / 21tk
edesia kaetud tablett
gedeon richter plc. - gestodeen+etünüülöstradiool - kaetud tablett - 75mcg+20mcg 21tk; 75mcg+20mcg 126tk
dexamethason krka süstelahus
krka d.d. novo mesto - deksametasoon - süstelahus - 4mg 1ml 1ml 25tk
orserdu
stemline therapeutics b.v. - elacestrant - rinnanäärmed - endokriinset ravi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
berlocid tablett
berlin-chemie ag - sulfametoksasool+trimetoprim - tablett - 800mg+160mg 10tk